# Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant

> **NCT01593215** · PHASE2 · COMPLETED · sponsor: **Anders Rosengren, MD PhD** · enrollment: 50 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Yohimbine

## Key facts

- **NCT ID:** NCT01593215
- **Lead sponsor:** Anders Rosengren, MD PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01593215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01593215, "Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01593215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*